Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
18:40:58 EDT Mon 07 Jul 2025
Enter Symbol
or Name
USA
CA



Q:DBVT - DBV TECHNOLOGIES SPON ADS EACH REPR 5 ORD SHS (R/S) - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
DBVT - Q5.010.52·13.080.111.03-0.90-7.517.117918311.51  11.51  11.0312.78  2.204516:00:02Jun 2515 min RT 2¢

Recent Trades - Last 10 of 183
Time ETExPriceChangeVolume
16:00:02Q11.01-0.5936
16:00:02Q11.01-0.592
16:00:02Q11.01-0.592
16:00:02Q11.01-0.592
16:00:02Q11.01-0.5958
15:57:24Q11.17-0.433
15:57:24Q11.17-0.431
15:57:24Q11.18-0.421
15:57:06Q11.03-0.90100
15:55:10Q11.05-0.551

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-06-25 16:15U:DBVTNews ReleaseDBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 - 3 Years Old
2025-06-12 16:05U:DBVTNews ReleaseDBV Technologies to Participate in Upcoming EAACI Congress 2025
2025-06-11 16:30U:DBVTNews ReleaseDBV Technologies Announces the Voting Results of its 2025 Combined General Meeting
2025-06-04 16:32U:DBVTNews ReleaseInformation Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 30, 2025
2025-06-03 16:30U:DBVTNews ReleaseDBV Technologies announces the filing of an addendum to the 2024 Universal Registration Document
2025-05-15 16:30U:DBVTNews ReleaseCombined General Meeting of June 11, 2025
2025-05-06 16:30U:DBVTNews ReleaseInformation regarding the total number of voting rights and total number of shares of the Company as of April 30, 2025
2025-05-05 16:30U:DBVTNews ReleaseDBV Technologies to Participate in the Citizens JMP Life Sciences Conference
2025-04-30 16:00U:DBVTNews ReleaseDBV Technologies Reports First Quarter 2025 Financial Results
2025-04-11 16:30U:DBVTNews ReleaseDBV Technologies announces filing of 2024 Annual Report on Form 10-K and Universal Registration Document
2025-03-27 22:30U:DBVTNews ReleaseDBV Technologies Announces Financing of up to $306.9 Million ( euros284.5 Million) to Advance Viaskin(TM) Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved
2025-03-24 02:30U:DBVTNews ReleaseDBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin(TM) Peanut Patch in 4-7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results...
2025-02-25 16:01U:DBVTNews ReleaseDBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress
2025-01-13 16:05U:DBVTNews ReleaseHalf-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
2025-01-08 16:05U:DBVTNews ReleaseDBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study
2024-12-11 16:05U:DBVTNews ReleaseDBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin(TM) Peanut Patch in Toddlers 1 - 3 Years-Old
2024-12-02 16:30U:DBVTNews ReleaseInformation regarding the total number of voting rights and total number of shares of the Company as of November 30, 2024
2024-11-11 16:30U:DBVTNews ReleaseDBV Technologies Announces Plan to Implement ADS Ratio Change
2024-11-06 16:30U:DBVTNews ReleaseDBV Technologies Reports Third Quarter 2024 Financial Results
2024-10-22 16:45U:DBVTNews ReleaseDBV Announces Positive Regulatory Updates for the Viaskin(TM) Peanut Patch in the United States and Europe